Skip to Content

Solanbridge Group Inc SLNX Stock Quote

| Rating as of


Market Closed

Chart Data Not Available

No price data available

  • Last Close 0.00
  • Sector Healthcare
  • Industry Drug Manufacturers - Specialty & Generic
  • Investment Style
  • Day Range < 0.01  –  < 0.01
  • Year Range < 0.01  –  < 0.01
  • Market Cap 15.4601
  • Volume / Avg 500.0 /  1.5 Mil
  • Price / Sales
  • Price / Book
  • Forward Div Yield 6.17%
  • Trailing Div Yield

Morningstar‘s Stock Analysis SLNX

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics SLNX

Company Profile SLNX

Business Description

Solanbridge Group Inc is based in Spring, Texas and is an innovative biotechnology company focusing on research, development, and production of nutraceutical and cosmetic products. The company is into medical marijuana industry, focuses on producing highest quality CBD hemp oil in Colorado, Nevada, and California. Its objective is to develop and offer specifically chosen products based on their effectiveness to manage various aspects of the customer's medical and personal needs.

3431 Rayford Road
Spring, TX, 77386
Industry Drug Manufacturers - Specialty & Generic

Competitors & Peers SLNX

Morningstar does not cover competitors or peers for this firm.

FAQs for Solanbridge Group Inc Stock

No. SLNX does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

SLNX’s market cap is 15.46.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

SLNX’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare SLNX’s historical performance against its industry peers and the overall market.